Retrospective analysis of the effect of treatment of osteosarcoma complicated by pathological fracture by neoadjuvant chemotherapy combined with limb salvage surgery.
To explore the efficacy of neoadjuvant chemotherapy combined with limb salvage surgery for the treatment of osteosarcoma complicated by pathological fracture. 215 osteosarcoma patients who were admitted in our hospital from 2001 and 2012 were followed up for 5 years and were retrospectively analyzed among them. The patients were divided into 4 groups based on their condition and treatment method to observe the 5-year overall survival and tumor-free survival (TFS) in each group. Adverse reactions caused by chemotherapy were recorded and analyzed. In addition, the quality of life was compared in these 4 groups. No significant differences were observed in postoperative overall survival and TFS between patients who were subjected to limb salvage surgery (Group A) and amputation (Group B). Similarly, there was no difference between patients who underwent surgery for pathological fracture and those without fracture (Group D). However, the survival of non-preoperative chemotherapy group (group C) was significantly different from that of preoperative chemotherapy group (group C vs group A/B/D, p=0.008, p=0.042, p=0.010, respectively). Besides, the TFS of non-preoperative chemotherapy group was significantly lower than that of preoperative chemotherapy group (group C vs. group A/B/D, p=0.012, p=0.002, p=0.008, respectively). Vomiting was the main adverse effect in our research. In the comparison of quality of life, social function and physical limitations in the limb-salvage group were superior to the amputation group. Neoadjuvant chemotherapy combined with limb salvage surgery is effective for the patients with osteosarcoma complicated by pathological fractures.